Literature DB >> 11926859

Patient and hospital characteristics associated with recommended processes of care for elderly patients hospitalized with pneumonia: results from the medicare quality indicator system pneumonia module.

Jonathan M Fine1, Michael J Fine, Deron Galusha, Marcia Petrillo, Thomas P Meehan.   

Abstract

BACKGROUND: Unexplained wide variability exists in the performance of key initial processes of care associated with improved survival of elderly patients (those > or =65 years) hospitalized with pneumonia. The objective of this study was to assess which patient and hospital characteristics are associated with performance of these key initial processes of care for hospitalized elderly patients with pneumonia.
METHODS: A retrospective cohort analysis was performed using data from the Medicare Quality Indicator System Pneumonia Module for 14 069 patients 65 years or older hospitalized with pneumonia throughout the United States. Associations were calculated using multivariate logistic regression analysis between specific patient and hospital characteristics and 2 processes of care associated with improved 30-day survival: administration of antibiotics within 8 hours of hospital arrival and blood culture collection within 24 hours of arrival.
RESULTS: Timely antibiotic administration was negatively associated with nonwhite race (African American: odds ratio [OR], 0.71; 95% confidence interval [CI], 0.60-0.85; and other racial minorities: OR, 0.79; 95% CI, 0.68-0.92), major hospital teaching status (OR, 0.79; 95% CI, 0.67-0.93), and larger hospital size (> or =250 beds vs. <100 beds: OR, 0.68; 95% CI, 0.59-0.80). Timely blood culture collection was positively associated with larger hospital size (OR, 1.61; 95% CI, 1.39-1.87). Performance of both processes of care were positively associated with registered nurse-bed ratios of 1.25 or higher (for antibiotic administration: OR, 1.23; 95% CI, 1.10-1.38; and for blood culture collection: OR, 1.43; 95% CI, 1.26-1.61) and fever (for antibiotic administration: OR, 1.35; 95% CI, 1.23-1.49; and for blood culture collection: OR, 3.07; 95% CI, 2.81-3.34) and were negatively associated with hospital location in the South (for antibiotic administration: OR, 0.77; 95% CI, 0.69-0.86; and for blood culture collection: OR, 0.85; 95% CI, 0.77-0.93).
CONCLUSIONS: Minority race, fever, nurse-bed ratio, hospital size and teaching status, and southern location are among the major patient and hospital characteristics associated, either negatively or positively, with the timeliness of performance of initial antibiotic administration and blood culture collection for patients hospitalized with pneumonia. Because performance of these processes of care is associated with improved likelihood of survival, medical providers should seek to eliminate the variations in care associated with these patient and hospital characteristics. In addition, the impact of nurse staffing changes on performance of key time-sensitive processes of care should be weighed carefully.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11926859     DOI: 10.1001/archinte.162.7.827

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  21 in total

1.  Is patient-perceived severity of a geriatric condition related to better quality of care?

Authors:  Lillian C Min; David B Reuben; Emmett Keeler; David A Ganz; Constance H Fung; Paul Shekelle; Carol P Roth; Neil S Wenger
Journal:  Med Care       Date:  2011-01       Impact factor: 2.983

2.  The Relative Ability of Comorbidity Ascertainment Methodologies to Predict In-Hospital Mortality Among Hospitalized Community-acquired Pneumonia Patients.

Authors:  Ronald E Weir; Christopher S Lyttle; David O Meltzer; Tien S Dong; Gregory W Ruhnke
Journal:  Med Care       Date:  2018-11       Impact factor: 2.983

3.  Hospitalist utilization and hospital performance on 6 publicly reported patient outcomes.

Authors:  Kate Goodrich; Harlan M Krumholz; Patrick H Conway; Peter Lindenauer; Andrew D Auerbach
Journal:  J Hosp Med       Date:  2012-06-11       Impact factor: 2.960

4.  Predictors of timely antibiotic administration for patients hospitalized with community-acquired pneumonia from the cluster-randomized EDCAP trial.

Authors:  Douglas J Hsu; Roslyn A Stone; D Scott Obrosky; Donald M Yealy; Thomas P Meehan; Jonathan M Fine; Louis G Graff; Michael J Fine
Journal:  Am J Med Sci       Date:  2010-04       Impact factor: 2.378

5.  Marked reduction in 30-day mortality among elderly patients with community-acquired pneumonia.

Authors:  Gregory W Ruhnke; Marcelo Coca-Perraillon; Barrett T Kitch; David M Cutler
Journal:  Am J Med       Date:  2011-02       Impact factor: 4.965

6.  Hospitals with the highest intensive care utilization provide lower quality pneumonia care to the elderly.

Authors:  Michael W Sjoding; Hallie C Prescott; Hannah Wunsch; Theodore J Iwashyna; Colin R Cooke
Journal:  Crit Care Med       Date:  2015-06       Impact factor: 7.598

7.  Do hospitals provide lower quality of care to black patients for pneumonia?

Authors:  Florian B Mayr; Sachin Yende; Gina D'Angelo; Amber E Barnato; John A Kellum; Lisa Weissfeld; Donald M Yealy; Michael C Reade; Eric B Milbrandt; Derek C Angus
Journal:  Crit Care Med       Date:  2010-03       Impact factor: 7.598

8.  Disparities of care for African-Americans and Caucasians with community-acquired pneumonia: a retrospective cohort study.

Authors:  Christopher R Frei; Eric M Mortensen; Laurel A Copeland; Russell T Attridge; Mary Jo V Pugh; Marcos I Restrepo; Antonio Anzueto; Brandy Nakashima; Michael J Fine
Journal:  BMC Health Serv Res       Date:  2010-05-27       Impact factor: 2.655

9.  Reporting hospitals' antibiotic timing in pneumonia: adverse consequences for patients?

Authors:  Mark W Friedberg; Ateev Mehrotra; Jeffrey A Linder
Journal:  Am J Manag Care       Date:  2009-02       Impact factor: 2.229

10.  Use of multidisciplinary rounds to simultaneously improve quality outcomes, enhance resident education, and shorten length of stay.

Authors:  Stephen O'Mahony; Eric Mazur; Pamela Charney; Yun Wang; Jonathan Fine
Journal:  J Gen Intern Med       Date:  2007-05-08       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.